Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

17.58 -1.52 (-7.96%)
Delayed Quote Updated: 2:26 PM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch. ↗
One of J&J's investments stands head-and-shoulders above the rest. 
Via The Motley Fool
News headline image
Procept BioRobotics CEO Buys 23,900 Shares Amid 48% Stock Decline. What Does This Tell Investors? ↗
Wood's $498,000 purchase through a trust vehicle expands his beneficial stake to 338,103 shares as the medical robotics firm navigates losses despite $337.3 million in trailing revenue. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
PROCEPT BioRobotics (PRCT) Q2 2026 Earnings Call Transcript ↗
HYDROS revenue surged 32% amid legacy account softness and accelerated replacements. 
Via The Motley Fool
Topics Earnings World Trade
Procept BioRobotics (NASDAQ:PRCT) Q2 In Line, But Unchanged Guidance Sinks Shares ↗
Via Chartmill
PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) Q1 Earnings Beat Drives 13% Surge Despite Net Loss ↗
Via Chartmill
Topics Earnings
News headline image
PROCEPT BioRobotics Q2 Earnings Call Highlights ↗
PROCEPT BioRobotics (NASDAQ:PRCT) reported second-quarter revenue growth of 19% year over year while lowering its full-year U.S. procedure outlook, citing softer activity at legacy AquaBeam accounts.... 
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch ↗
Biotech firm Nektar Therapeutics advances a pipeline of immunology and oncology candidates through research-driven collaborations. 
Via The Motley Fool
News headline image
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗
GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions. 
Via The Motley Fool
Topics Artificial Intelligence
PROCEPT BioRobotics Corp (NASDAQ:PRCT) Plummets 27% After Q4 Earnings Miss and Slashed 2026 Guidance ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
 
Via Benzinga
News headline image
5 Robotics Stocks to Watch as Physical AI Builds Momentum ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Procept (PRCT) Q1 2026 Earnings Transcript ↗
Procept (PRCT) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock ↗
This surgical robotics firm develops minimally invasive systems for urologic procedures, targeting hospitals and specialty clinics. 
Via The Motley Fool
News headline image
PROCEPT BioRobotics (PRCT) Earnings Transcript ↗
PROCEPT BioRobotics (PRCT) Earnings Transcript 
Via The Motley Fool
Topics World Trade
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session. ↗
Via Chartmill
News headline image
PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why ↗
PROCEPT BioRobotics (NASDAQ: PRCT) shares down on Q4 2025 results and updated revenue guidance. Q1 sales expected at $79-82 million. 
Via Benzinga
News headline image
PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 ↗
Bank of America reduced its rating on PROCEPT BioRobotics to ‘Underperform’ from ‘Neutral’. 
Via Stocktwits
Topics Artificial Intelligence
Top movers in Wednesday's after hours session ↗
Via Chartmill
News headline image
After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Million ↗
This healthcare technology firm develops robotic surgical systems for minimally invasive urology procedures targeting BPH treatment. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Underrated Robotics Stocks Poised for Huge Gains ↗
Via MarketBeat
News headline image
2 Robotics Stocks Riding the Sensor and Medical Boom ↗
The robotics infrastructure layer is delivering explosive returns. 
Via The Motley Fool
News headline image
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? ↗
Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? 
Via The Motley Fool
News headline image
Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock ↗
 
Via Benzinga
News headline image
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts ↗
 
Via Benzinga
News headline image
Procept (PRCT) Q2 Revenue Jumps 48% ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
PROCEPT BioRobotics (PRCT) Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline ↗
PROCEPT BioRobotics posted strong Q2 2025 revenue growth of 48% YoY but missed profitability estimates, triggering an 8% stock drop. The surgical robotics firm raised full-year guidance but faces... 
Via Chartmill
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.